Bristol-Myers Squibb Co. (NYSE:BMY) does about 15.85M shares in volume on a normal day but saw 9119628 shares change hands in Monday trading. The company now has a market cap of 88.99B USD. Its current market price is $43.90, marking a decrease of -0.20% compared to the previous close of $43.99. The 52 week high reached by this stock is $69.10 whilst the lowest price level in 52 weeks is $43.33.
Bristol-Myers Squibb Co. (BMY) has a 20-day trading average at $47.10 and the current price is -36.47% off the 52-week high compared with 1.31% distance from its 52-week low. The 50-day simple moving average of the closing price is $50.16 and its 200-day simple moving average is $53.56. If we look at the stock’s price movements over the week, volatility stands at 1.90%, which increases to 1.96% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 25.47 to suggest the stock is oversold.
The consensus objective for the share price is $52.76, suggesting that the stock has a potential upside of 16.79% over the period.
Redburn Atlantic also downgraded the stock to “Neutral” from Buy on February 06, 2024 at a price target of $77-$54. BofA Securities downgraded its price target at $68-$60.
Bristol-Myers Squibb Co. (BMY) stock is down -1.66% over the week and -14.46% over the past month. Its price is -14.44% year-to-date and -34.30% over the past year.
To reach the target analysts have set, the stock logically needs to grow 16.79 percent from here.
The company has a return on investment of -9.10% and return on equity of -25.45%. The forward price to earnings ratio is 6.33. The beta has a value of 0.45. Price to book ratio is 5.40 and price to sales ratio is 1.95.
